Amplify Weight Loss Drug & Treatment ETF (THNR) Holdings List

$24.76 +0.08 (+0.32%)

As of 04:10 PM Eastern

What stocks does THNR hold?

The Amplify Weight Loss Drug & Treatment ETF (THNR) top stock holdings include Novo Nordisk A/S, Eli Lilly and Company, and Regeneron Pharmaceuticals. The top 22 THNR holdings ordered by weight make up 100.00% of the total fund. THNR is an equity fund in the strategy category that invests in publicly traded companies and other investments, focused on theme strategies within the Global region. This page includes a complete THNR stock holdings list ranked by weight, along with a full breakdown of sector, geographic, industry, and currency exposure.

Top 22 THNR Holdings

Rank	Company	Current Price	Weight	Shares Held
1	NVO Novo Nordisk A/S	$44.87 +1.1%	13.85%	13,608
2	LLY Eli Lilly and Company	$989.02 +2.2%	11.91%	529
3	REGN Regeneron Pharmaceuticals	$702.45 -1.0%	6.29%	369
4	AMGN Amgen	$329.59 +1.8%	6.25%	749
5	ARWR Arrowhead Pharmaceuticals	$74.93 -1.9%	5.82%	3,287
6	Chugai Pharmaceutical Co., Ltd.	N/A	5.74%	4,600
7	Innovent Biologics, Inc.	N/A	5.54%	20,000
8	Roche Holding AG	N/A	5.00%	510
9	PFE Pfizer	$26.42 +0.5%	4.89%	7,606
10	AstraZeneca PLC	N/A	4.80%	1,063
11	CSPC Pharmaceutical Group Limited	N/A	4.66%	180,000
12	MRK Merck & Co., Inc.	$113.21 +0.1%	4.64%	1,763
13	ABBV AbbVie	$206.12 -1.0%	4.62%	907
14	Shionogi & Co., Ltd.	N/A	4.53%	9,300
15	SRRK Scholar Rock	$47.13 +1.4%	2.25%	2,005
16	VKTX Viking Therapeutics	$31.31 -1.4%	2.12%	2,818
17	Zealand Pharma A/S	N/A	1.82%	1,604
18	GPCR Structure Therapeutics	$41.10 -4.5%	1.74%	1,738
19	Jiangsu Hengrui Pharmaceuticals Co Ltd Ordinary Shares - Class H	N/A	1.24%	6,200
20	Hanmi Pharm. Co., Ltd.	N/A	1.18%	158
21	Short-Term Investment Trust - Invesco Government & Agency Portfolio	N/A	0.95%	39,342
22	OTHER ASSETS AND LIABILITIES	N/A	0.16%	142,614,417

THNR Geographic Exposure

THNR's largest geographic exposure is United States at 65.6%, followed by Japan at 10.2%.

United States
65.6%
Japan
10.2%
Cayman Islands
5.6%
United Kingdom
4.7%
Hong Kong
4.6%
Denmark
1.8%
Korea, Republic of
1.1%

THNR Currency Exposure

THNR's largest currency exposure is USD at 75.4%, followed by HKD at 11.5%.

USD
75.4%
HKD
11.5%
JPY
10.2%
DKK
1.8%
KRW
1.1%

THNR Sector Exposure

THNR's largest sector exposure is Health Care at 92.7%.

Health Care
92.7%

THNR Industry Exposure

THNR's largest industry exposure is Biotechnology at 90.9%, followed by Pharmaceuticals at 1.8%.

Biotechnology
90.9%
Pharmaceuticals
1.8%

THNR Sub-Industry Exposure

THNR's largest sub-industry exposure is Biotechnology at 90.9%, followed by Pharmaceuticals at 1.8%.

Biotechnology
90.9%
Pharmaceuticals
1.8%

Related Companies and Tools

Related Companies

This page (NYSEARCA:THNR) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Amplify Weight Loss Drug & Treatment ETF (THNR) Holdings List